Roche Media 3. Nov. 2025 Roche’s Phase III trial of Gazyva/Gazyvaro for SLE meets primary endpoint - Clinical Trials Arena #Phase III #III trial
Cytiva (Google News) 23. Dez. 2024 When Inherency Meets Obvious-to-Try: How Cytiva V. JSR Clarifies The Patent Obviousness Analysis - Mondaq #Inherency Meets #JSR Clarifies